ConductScience.org, home

Library / Genes

L1CAM: L1 cell adhesion molecule

1 protein, 103 patents, 0 drugs, 0 trials, 2,651 NIH grants and 4,736 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolL1CAMHGNC
NameL1 cell adhesion moleculeHGNC
NCBI Gene ID3897NCBI Gene
HGNC IDHGNC:6470HGNC
EnsemblENSG00000198910NCBI Gene
AliasesCAML1, CD171, HSAS, HSAS1, HYCX, MASA, MIC5, N-CAM-L1, N-CAML1, NCAM-L1, S10, SPG1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P32004Neural cell adhesion molecule L11,2572Ensembl, GeneID, HGNCUniProt

Patents 103

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026503265 A2026-01-281P32004Espacenet
JP 2026004568 A2026-01-1451016P32004Espacenet
JP 2026004568 A2026-01-1451017P32004Espacenet
US 12509513 B22025-12-301P32004Espacenet
EP 4649094 A12025-11-191P32004Espacenet
EP 4650780 A22025-11-198711P32004Espacenet
EP 4646227 A12025-11-121P32004Espacenet
EP 4641201 A22025-10-298910P32004Espacenet
JP 2025147176 A2025-10-067620P32004Espacenet
JP 2025531671 A2025-09-2515P32004Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2651

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant432,025NIH's project files
ZIAAG000975ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders402,025NIH's project files
P30CA016672Cancer Center Support Grant162,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award162,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant102,025NIH's project files
ZIAAG000003ALZHEIMERS RESEARCH PROJECT: Developing Extraceullar Vesicle biomarkers for clinical and preclinical AD/ADRD102,025NIH's project files
P30CA016058Cancer Center Support Grant82,025NIH's project files
U24AA014811Administrative Resource of the CIFASD72,025NIH's project files
P30AG066507Johns Hopkins Alzheimer's Disease Research Center52,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program52,025NIH's project files

Papers 4736

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42814818PubTator, text miningPubMed
42793688PubTator, text miningPubMed
42792643PubTator, text miningPubMed
42768739PubTator, text miningPubMed
42759981PubTator, text miningPubMed
42754233PubTator, text miningPubMed
42723080PubTator, text miningPubMed
42722081PubTator, text miningPubMed
42682089PubTator, text miningPubMed
42677823PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license